Cg Oncology Inc.
CGON
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.28B
Close$
$-4.32
106.1% downside
Current Fair Value
106.1% downsideOvervalued by 106.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.28 Billion |
|---|---|
| Enterprise Value | $6.25 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.08 |
| Beta | 0.22 |
| Outstanding Shares | 84,518,512 |
Return
| Return on Equity | -3.78% |
|---|---|
| Return on Assets | -3.64% |
| Return on Invested Capital | -18.87% |
Valuation & Multiples
| P/E Ratio | -30.42 |
|---|---|
| PEG | 30.42 |
| Price to Sales | - |
| Price to Book Ratio | 5.95 |
| Enterprise Value to Revenue | 1233.09 |
| Enterprise Value to EBIT | -30.13 |
| Enterprise Value to Net Income | -152 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$360,805
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 43.95% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.48%▼ 112.53% |
|---|---|
| Total Invested | $88.30M▼ 98.51% |
| Investors Holding | 38▼ 208.00% |
ESG Score
No data